Iteration is not solving the opioid crisis, it's time for transformation

被引:4
作者
Dunn, Kelly E. E. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA
关键词
Opioid; fentanyl; heroin; harm reduction; treatment; opioid use disorder; METHADONE-MAINTENANCE TREATMENT; UNITED-STATES; AGONIST TREATMENT; HEROIN-ADDICTION; OVERDOSE DEATHS; ORAL METHADONE; USE DISORDER; BUPRENORPHINE; DIACETYLMORPHINE; PHARMACOKINETICS;
D O I
10.1080/00952990.2023.2170807
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Opioid use disorder (OUD) produces exceedingly high rates of morbidity and mortality in the United States and throughout the world. Almost 90% of persons qualifying for treatment do not enter treatment and 72% of those who initiate treatment leave within 60 days. This Perspective posits that over the past decade our OUD treatment system has produced only small iterative gains in treatment access because, in part, it is founded in a series of top-down regulatory policies dating back more than 100 years. These policies prioritized restricting persons with OUD from having access to opioid agonists over empirical discovery of treatment best practice. It further suggests that for persons who are not already responding positively to our existing treatments, we may need to fundamentally transform care to enact true, meaningful change. Four potential considerations are outlined: expanding beyond long-acting opioids for treatment, embracing safe use as a viable therapeutic target, ending closed medication distribution systems, and partnering with our patients. The overarching aim of this discussion is to motivate broader thinking about new solutions for the patients for whom the existing strategies are not working and who may benefit from more transformative approaches. Though efforts to-date to expand existing treatment systems and find new ways to promote existing MOUDs have been important, these efforts have represented iterative changes. For us to meet our goal of substantially reducing opioid-related harms, it may be time to consider strategies that represent true transformation.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [31] Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now
    Kim, Eun-Ji
    Hwang, Eun-Jung
    Yoo, Yeong-Min
    Kim, Kyung-Hoon
    KOREAN JOURNAL OF PAIN, 2022, 35 (04) : 361 - 382
  • [32] Federal Response to the Opioid Crisis
    Johnson, Kimberly
    Jones, Chris
    Compton, Wilson
    Baldwin, Grant
    Fan, Jennifer
    Mermin, Jonathan
    Bennett, Jean
    CURRENT HIV/AIDS REPORTS, 2018, 15 (04) : 293 - 301
  • [33] Food Insecurity and the Opioid Crisis
    Heflin, Colleen
    Sun, Xiaohan
    ANNALS OF THE AMERICAN ACADEMY OF POLITICAL AND SOCIAL SCIENCE, 2022, 703 (01) : 262 - 284
  • [34] Contaminated Relationships in the Opioid Crisis
    Gentry, Elissa Philip
    McMichael, Benjamin J.
    HASTINGS LAW JOURNAL, 2021, 72 (03) : 827 - 870
  • [35] Emergency department strategies to combat the opioid crisis in children and adolescents
    Chang, Cindy D.
    Saidinejad, Mohsen
    Atanelov, Zaza
    Dietrich, Ann M.
    Lam, Samuel Hiu-Fung
    Rose, Emily
    Ruttan, Tim
    Shahid, Sam
    Stoner, Michael J.
    Sulton, Carmen
    Chumpitazi, Corrie E.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2021, 2 (04)
  • [36] The payer's role in addressing the opioid epidemic: It's more than money
    Molfenter, Todd
    McCarty, Dennis
    Jacobson, Nora
    Kim, Jee-Seon
    Starr, Sanford
    Zehner, Mark
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 101 : 72 - 78
  • [37] Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective
    Gadd, Shannon
    Cox, Nicholas
    Samuelson, James
    Kenney, Amy
    Turner, Kyle
    Cochran, Gerald
    THERAPEUTIC DRUG MONITORING, 2021, 43 (01) : 35 - 41
  • [38] The Opioid Crisis
    Nesbit, Suzanne A.
    Bicket, Mark C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (02) : 83 - 85
  • [39] Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder COMMENT
    Luli, Alex J.
    Bounthavong, Mark
    Watanabe, Jonathan H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (02) : 297 - 303
  • [40] A Public Health Strategy for the Opioid Crisis
    Saloner, Brendan
    McGinty, Emma E.
    Beletsky, Leo
    Bluthenthal, Ricky
    Beyrer, Chris
    Botticelli, Michael
    Sherman, Susan G.
    PUBLIC HEALTH REPORTS, 2018, 133 : 24S - 34S